###begin article-title 0
###xml 24 39 24 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tropomodulins 2</italic>
###xml 44 45 44 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">4</italic>
###xml 97 101 97 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 106 120 106 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tropomodulin 4</italic>
Genomic organization of Tropomodulins 2 and 4 and unusual intergenic and intraexonic splicing of YL-1 and Tropomodulin 4
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 378 400 378 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tropomodulin 2 (TMOD2)</italic>
###xml 630 653 630 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tropomodulin 4 (TMOD4).</italic>
###xml 132 138 <span type="species:ncbi:9606">humans</span>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
###xml 242 247 <span type="species:ncbi:9606">human</span>
###xml 559 566 <span type="species:ncbi:9606">patient</span>
The tropomodulins (TMODs) are a family of proteins that cap the pointed ends of actin filaments. Four TMODs have been identified in humans, with orthologs in mice. Mutations in actin or actin-binding proteins have been found to cause several human diseases, ranging from hypertrophic cardiomyopathy to immunodefiencies such as Wiskott-Aldrich syndrome. We had previously mapped Tropomodulin 2 (TMOD2) to the genomic region containing the gene for amyotrophic lateral sclerosis 5 (ALS5). We determined the genomic structure of Tmod2 in order to better analyze patient DNA for mutations; we also determined the genomic structure of Tropomodulin 4 (TMOD4).
###end p 2
###begin title 3
Results
###end title 3
###begin p 4
###xml 54 59 54 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD2</italic>
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 147 152 147 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD2</italic>
###xml 270 275 270 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1,</italic>
###xml 304 315 304 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4. YL-1</italic>
###xml 394 400 394 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4.</italic>
###xml 433 438 433 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 485 489 485 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 200 208 <span type="species:ncbi:9606">patients</span>
In this study, we determined the genomic structure of TMOD2 and TMOD4 and found the organization of both genes to be similar. Sequence analysis of TMOD2 revealed no mutations or polymorphisms in ALS5 patients or controls. Interestingly, we discovered that another gene, YL-1, intergenically splices into TMOD4. YL-1 encodes six exons, the last of which is 291 bp from a 5' untranslated exon of TMOD4. We used 5' RACE and RT-PCR from TMOD4 to identify several intergenic RACE products. YL-1 was also found to undergo unconventional splicing using non-canonical splice sites within exons (intraexonic splicing) to produce several alternative transcripts.
###end p 4
###begin title 5
Conclusions
###end title 5
###begin p 6
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD2</italic>
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 165 175 165 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4/YL-1</italic>
The genomic structure of TMOD2 and TMOD4 have been delineated. This should facilitate future mutational analysis of these genes. In addition, intergenic splicing at TMOD4/YL-1 was discovered, demonstrating yet another level of complexity of gene organization and regulation.
###end p 6
###begin title 7
Background
###end title 7
###begin p 8
###xml 90 91 90 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 104 123 104 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tropomodulin (TMOD)</italic>
###xml 323 334 323 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila,</italic>
###xml 339 349 339 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. elegans</italic>
###xml 350 351 350 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 352 353 352 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 394 416 394 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tropomodulin 3 (TMOD3)</italic>
###xml 432 454 432 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tropomodulin 1 (TMOD1)</italic>
###xml 530 552 530 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tropomodulin 2 (TMOD2)</italic>
###xml 587 610 587 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tropomodulin 4 (TMOD4).</italic>
###xml 729 730 729 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 909 910 898 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 911 913 900 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1013 1015 1002 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1156 1161 1145 1150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tmod1</italic>
###xml 1248 1250 1237 1239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1251 1253 1240 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1256 1261 1245 1250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tmod1</italic>
###xml 1407 1409 1396 1398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1442 1447 1431 1436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD1</italic>
###xml 1592 1594 1581 1583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1901 1903 1890 1892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 2011 2013 2000 2002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 2014 2016 2003 2005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 2035 2039 2024 2028 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TPM1</italic>
###xml 2222 2224 2211 2213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 2342 2344 2331 2333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 254 260 <span type="species:ncbi:9606">humans</span>
###xml 304 309 <span type="species:ncbi:10090">mouse</span>
###xml 311 314 <span type="species:ncbi:10116">rat</span>
###xml 316 321 <span type="species:ncbi:9031">chick</span>
###xml 323 333 <span type="species:ncbi:7227">Drosophila</span>
###xml 339 349 <span type="species:ncbi:238774|species:ncbi:386067|species:ncbi:147878|species:ncbi:193182|species:ncbi:313250|species:ncbi:323266|species:ncbi:315362|species:ncbi:148887|species:ncbi:124036|species:ncbi:48798|species:ncbi:529401|species:ncbi:314391|species:ncbi:646318|species:ncbi:254962|species:ncbi:323047|species:ncbi:287681|species:ncbi:269614|species:ncbi:103475|species:ncbi:114942|species:ncbi:212608|species:ncbi:457136|species:ncbi:227469|species:ncbi:449387|species:ncbi:551876|species:ncbi:248142|species:ncbi:252961|species:ncbi:466267|species:ncbi:119832|species:ncbi:228196|species:ncbi:316080|species:ncbi:217897|species:ncbi:109099|species:ncbi:328850|species:ncbi:266263|species:ncbi:348465|species:ncbi:181251|species:ncbi:6239|species:ncbi:320029|species:ncbi:293163|species:ncbi:4853|species:ncbi:160529|species:ncbi:292745|species:ncbi:368875|species:ncbi:323318|species:ncbi:209968|species:ncbi:405608|species:ncbi:480533">C. elegans</span>
###xml 1280 1283 <span type="species:ncbi:10116">rat</span>
###xml 1422 1426 <span type="species:ncbi:10090">mice</span>
###xml 1677 1682 <span type="species:ncbi:9031">chick</span>
###xml 2134 2139 <span type="species:ncbi:10090">mouse</span>
Tropomodulins are the vertebrate proteins that cap the pointed ends of filamentous actin [1]. The first tropomodulin (TMOD) gene was cloned by Sung and colleagues (1992) from a fetal liver library. Three additional family members have been identified in humans, and TMOD homologs have been identified in mouse, rat, chick, Drosophila, and C. elegans[2-8]. Expression patterns vary extensively: Tropomodulin 3 (TMOD3) is ubiquitous; Tropomodulin 1 (TMOD1) is widespread in heart, muscle, brain, lens, erythrocytes, and arterioles; Tropomodulin 2 (TMOD2) is restricted to neuronal tissue; Tropomodulin 4 (TMOD4). is expressed in skeletal muscle, with a less abundant ~7 kb transcript expressed in both skeletal and cardiac muscle [8]. Whereas tropomodulins or the Arp 2/3 complex cap the pointed end of actin filaments, the barbed end can be capped by CapZ, alpha, beta, and gamma adducins as well as gelsolin [9-11]. Control of thin filament length is critical for maintaining proper sarcomere function and length[12]. Inhibition of Tmod1's capping activity - either by using an antibody to its C-terminal end or by decreasing expression using an antisense Tmod1 transcript - results in elongated thin filaments and decreased cardiac contractility [13,14]. Tmod1 overexpression in rat cardiomyocytes causes shortening of the thin filaments and sarcomere disorganization, resulting in myofibril degeneration [14]. Likewise, mice overexpressing TMOD1 in the heart show disrupted sarcomere organization with shortened thin filaments, leading to myofibril degeneration and dilated cardiomyopathy [15]. Recently, Littlefield and colleagues showed that overexpression of GFP-Tmod1 in chick cardiac myocytes results in shortening of thin filaments; the authors proposed that excess Tmod1 decreases the affinity between actin monomers and pointed ends, leading to monomer dissociation and filament shortening [42]. Mutations in many proteins making up the cardiac sarcomere have been shown to cause cardiac hypertrophy [16-19]:mutations in the TPM1 gene, for example, cause type 3 familial hypertrophic cardiomyopathy (CMH3), and a transgenic mouse expressing a CMH3 mutation develops ventricular myocyte disarray and hypertrophy [20]. Mutations in myosin heavy chain 7 are estimated to account for 40-50% of the cases of hypertrophic cardiomyopathy [21].
###end p 8
###begin p 9
###xml 75 80 75 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD2</italic>
###xml 85 90 85 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 153 154 153 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 505 507 505 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 571 576 571 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1,</italic>
###xml 605 617 605 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4 . YL-1</italic>
###xml 711 713 711 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 714 716 714 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 719 723 719 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 877 881 877 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 886 891 886 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 50 55 <span type="species:ncbi:9606">human</span>
Given the importance of actin-binding proteins in human disease, we mapped TMOD2 and TMOD4 and found them to localize to 15q21.1 and 1q12, respectively [8]. These loci overlap with the genomic regions containing the genes for amyotrophic lateral sclerosis 5 (ALS5) and limb girdle muscular dystrophy 1B (LGMD1B), respectively [22,23]. We characterized these tropomodulin genomic loci for use in mutational analysis. During the course of this study, the gene mutated in LGMD1B was identified as Lamin A/C [24]. Our investigation, however, revealed that an unrelated gene, YL-1, intergenically spliced into TMOD4 . YL-1 is a putative transformation suppressor gene that localizes to the nucleus and binds to DNA [25,26]. YL-1 is organized into six exons and produces several alternatively spliced transcripts using both intergenic and cryptic splicing. This relationship between YL-1 and TMOD4 serves as yet another example of the complexity of genomic organization and gene regulation.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
Genomic organization of TMOD2, TMOD4, and YL-1
###end title 11
###begin p 12
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD2</italic>
###xml 54 59 54 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 224 229 224 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD2</italic>
###xml 237 242 237 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 319 320 319 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 394 399 394 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD2</italic>
###xml 464 466 464 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3'</italic>
###xml 486 508 486 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4. TMOD2 and TMOD4</italic>
###xml 667 668 667 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 710 718 710 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4 5'</italic>
###xml 867 872 867 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 979 984 979 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 1095 1100 1095 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 1192 1197 1192 1197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
We determined the exon/intron boundaries of TMOD2 and TMOD4 by sequencing PCR products amplified from primers within adjacent exons, and sequencing short exon containing genomic fragments. We identified nine coding exons in TMOD2 and in TMOD4 which are spread over a 45 kb and 4.7 kb genomic region, respectively (Fig. 1). The exon/intron boundaries of the two genes are conserved, except that TMOD2 has more 5' untranslated region (UTR) in coding exon 1 and more 3' UTR in exon 9 than TMOD4. TMOD2 and TMOD4 also contain additional 5' UTR exons. Our reported cDNAs have 69 and 19 bp additional sequence 5' to what is contained in exon 1 for each gene, respectively [8]. A search of the EST database using the TMOD4 5' end extended this sequence by 8 bp (ESTs AA194560, AA192772, and AA178988). We were able to align this sequence and found that it lies 1006 bp from TMOD4 exon 1 and contained a consensus donor splice site. Using 5' rapid amplification of cDNA ends (RACE) from TMOD4 exon 2, we discovered that this exon was 93 bp in length and contained no consensus AG acceptor. 3' RACE from TMOD4 exon 2 extended our reported cDNA by an additional 9 bp, bringing the entire length of the TMOD4 transcript to 1.267 kb (Genbank Accession# AF393374).
###end p 12
###begin p 13
###xml 21 34 21 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD2, TMOD4,</italic>
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1.</italic>
Genomic structure of TMOD2, TMOD4, and YL-1. Numbered rectangles represent coding exons, E0 represents 5' UTR exons. ATG represents the start codon of each gene and TAA or TAG represent the termination codon of each gene. Scale below is in kilobases (kb).
###end p 13
###begin p 14
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD2</italic>
###xml 192 197 192 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD2</italic>
###xml 450 452 450 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
Using the 5' end of the TMOD2 cDNA, we searched the high throughput genomic sequences (HTGS) database and identified a sequence, NT 010204, that contained 100% identity to the 69 basepairs of TMOD2 5' UTR and contained a consensus GT donor splice site. The distance from this UTR exon to coding exon 1 is 14.6 kb, but the sequence is not completely ordered. Using nomenclature from previous tropomodulin genes we designated these 5' UTR exons as E0 [27].
###end p 14
###begin p 15
###xml 48 52 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 125 130 125 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 218 222 218 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 246 247 246 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 285 289 285 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 296 301 296 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 365 370 365 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 387 391 387 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 407 412 407 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 547 560 547 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD2, TMOD4,</italic>
###xml 565 569 565 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 594 595 594 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 645 657 645 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tropomodulin</italic>
###xml 669 673 669 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 900 902 900 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 936 940 936 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 1069 1071 1069 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3'</italic>
We sought to determine the genomic structure of YL-1 when we discovered that it lies next to and intergenically splices into TMOD4 (see below). Using the same methods described above, we identified six coding exons of YL-1 spanning 14.2 kb (Fig. 1). The distance from the last exon of YL-1 to E0 TMOD4 is 291 bp. We sequenced the entire genomic region encompassing TMOD4 from the end of YL-1 exon 6 through TMOD4 exon 9 and deposited it in Genbank (Accession No. AF393375). The sizes of the exons and introns as well as the boundary sequences for TMOD2, TMOD4, and YL-1 are provided (See Table 1). Consensus splice sites were identified for all Tropomodulin exons, but YL-1 exon 1 contained a GC 5' splice site instead of the more common GT 5' splice site. This splice site also conforms well to other nonconsensus GC 5' splice sites as described in Mount (2000) with a G at the -1 and +5 positions [28]. We used the very 3' end of the YL-1 cDNA to look for additional 3' UTR. We identified three ESTs (ESTs AA128103, AW627363, and AI591193) that were identical at the 3' end and extended the reported UTR by an additional 150 bp.
###end p 15
###begin title 16
Mutational Analysis of TMOD2 in ALS5
###end title 16
###begin p 17
###xml 131 137 131 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD2.</italic>
###xml 212 213 212 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 4 12 <span type="species:ncbi:9606">patients</span>
###xml 375 383 <span type="species:ncbi:9606">patients</span>
Two patients and two controls from a family with an autosomal recessive form of familial ALS (ALS5) were analyzed for mutations in TMOD2. We amplified coding exons 1-9 using primers flanking each exon (See Table 2). These PCR products were sequenced to identify any potential point mutations or small deletions. We did not detect any mutations or polymorphisms in any of the patients or controls.
###end p 17
###begin title 18
Inter genic splicing of YL-1 into TMOD4
###end title 18
###begin p 19
###xml 23 30 23 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4's</italic>
###xml 92 97 92 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 170 175 170 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1.</italic>
###xml 305 306 305 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 553 557 553 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 573 578 573 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 645 649 645 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 666 671 666 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 878 882 878 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 1148 1152 1148 1152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 1167 1173 1167 1173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4,</italic>
###xml 1328 1332 1328 1332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 1356 1361 1356 1361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 1404 1405 1404 1405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 1491 1497 1491 1497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4,</italic>
###xml 1624 1628 1624 1628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 1647 1652 1647 1652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 1741 1745 1741 1745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 1799 1804 1799 1804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 1843 1847 1843 1847 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 2235 2241 2235 2241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4.</italic>
###xml 2285 2289 2285 2289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 2341 2346 2341 2346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 2593 2597 2593 2597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 1240 1245 <span type="species:ncbi:9606">human</span>
During our analysis of TMOD4's genomic structure we identified EST AI763406, which contains TMOD4 exon 9 and part of the coding region of another unrelated gene known as YL-1. Using 5' RACE we were able to confirm the presence of this transcript and identify other unique intergenic RACE products. Figure 2 summarizes our findings. There are two main intergenic products, each of which was represented multiple times in our RACE clones. The first intergenic splice products (RACE #9-11, and 13-15) are similar to EST AI763406. These variants consist of YL-1 exons 1-5, and TMOD4 exon 9. The ORF of this splice variant keeps the reading frame of YL-1 but changes the TMOD4 endogenous reading frame to make the reading frame of exon 9 completely open. Translation of this ORF would theoretically produce a protein of at least 271 amino acids containing the amino terminal half of YL-1 but a unique carboxy terminus. If, however, we extend the sequence to include intronic sequence downstream of exon 9, we discover that the frame is kept open an additional 45 bp, making this theoretical protein 286 amino acids in length. Using primers to exon 1 of YL-1 and exon 9 of TMOD4, we confirmed the presence of this intergenic product by RT-PCR on human heart RNA. RACE product #12 was similar to RACE products #9-11, 13-15 except that YL-1 splices from exon 5 to TMOD4 exon 8 which then splices to exon 9 (Fig. 2). This produces an ORF coding for a 252 amino acid protein that changes the frame of TMOD4, adding only 16 additional amino acids before encountering a stop codon. Another set of RACE products (RACE # 1-5) consists of YL-1 exons 4 and 5 and TMOD4 exons 1-9, except that exon 2 uses an internal consensus cryptic splice site. Using the YL-1 endogenous frame we find that this ORF terminates in TMOD4 exon 1. If we assume an ORF including YL-1 exons 1-3 along with the isolated RACE product, then it would theoretically produce a protein of 264 amino acids. We used the translated protein sequences from these intergenic ORFs and analyzed them using InterPro Scan via EXPASY. No additional sequence motifs or domains were identified. Another type of RACE product we identified (RACE# 26-31) is the incompletely spliced products of TMOD4. In no case did we observe the inclusion of YL-1 exon 6 or the use of the normal splice acceptor of TMOD4 exon 2 - the cryptic splice acceptor was always present in intergenic RACE products. Furthermore, the YL-1 alpha helical domain, which is thought to contain the DNA binding domain, is maintained in all intergenic splice products contained within YL-1 exons 4 and 5.
###end p 19
###begin p 20
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 105 110 105 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
Summary of RACE products: Hatched rectangles represent YL-1 exons. Diagonal striped rectangles represent TMOD4 exons. Numbers in parentheses represent the number of amino acids produced from each ORF. Black rectangles represent introns, and horizontally striped rectangles represent exons which used a cryptic splice site.
###end p 20
###begin title 21
YL-1 intraexonic spliced transcripts and expression pattern
###end title 21
###begin p 22
###xml 35 41 35 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1's</italic>
###xml 129 133 129 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 164 168 164 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 172 177 172 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 322 326 322 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 508 510 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 569 573 569 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 729 730 729 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 919 923 919 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 1193 1194 1193 1194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1393 1397 1393 1397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 1541 1542 1541 1542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1665 1669 1665 1669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 2116 2120 2116 2120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 2187 2191 2187 2191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 2572 2576 2572 2576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 2743 2747 2743 2747 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 2752 2758 2752 2758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4,</italic>
###xml 209 214 <span type="species:ncbi:9606">human</span>
To better understand the nature of YL-1's intergenic splicing, we searched the EST database for other alternative and intergenic YL-1 transcripts. Using either the YL-1 or TMOD4 cDNAs in a BLAST search of the human EST database, we were unable to identify any additional intergenic transcripts, but we did uncover several YL-1 ESTs that had apparently spliced within exons in such a way as to not use the canonical consensus splice acceptors or donors, the rarer GC or AT donor sites or the AC acceptor site[29]. ESTs AI560960 and AI369608 were identical and contained YL-1 exons 1 and 2 but splice within exon 2 at position 276 (position is in bp relative to Genbank sequence D43642) to position 1107 (internal to exon 6) (Fig. 3). Translation of this ORF would produce a truncated protein of only 121 amino acids. EST AI560960 was obtained from the IMAGE consortium and sequenced. It is 476 bp in length and contains YL-1 exons 1 and up to position 276 in exon 2 at which it splices internal to exon 6 at position 1107. A second splice product was represented by ESTs AI366716 and AW005187, in which the sequence appears to splice from position 113 in exon 1 to exon 6 at position 936 (Fig. 3). This would produce another truncated protein that is 89 amino acids in length. Another unusual splice product was represented by ESTs AA443950 and AA653180. These ESTs demonstrate splicing within YL-1 exon six itself, from position 936 to 1062 (skipping over ~126 bp), changing the frame and making it open past the endogenous stop codon (Fig. 3). EST AA443950 was obtained from the image consortium and sequenced. It contained a 1199 bp insert which contained all of YL-1 exons 1-5 and exon six as described above and encodes an ORF for a 358 amino acid protein. However, EST AA653180 has an additional six base pairs at the splice junction site coding for leucine and proline, suggesting that either the site produces two different splice variants or there is some type of intermediate stage of splicing at this site. In either case, the protein produced from this ORF (if AA653180 contains the rest of the intact 5' YL-1 transcript) would be 360 amino acids. This truncates the reported YL-1 protein only by 6 or 4 amino acids. Using InterPro Scan via EXPASY, we determined that these few amino acids do not produce any potential phosphorylation sites or protein domains or motifs. Two of these three splice variants use the 936 position for splicing as a putative donor in one case and as an acceptor in the other. We cannot explain this finding, but it may suggest that YL-1 undergoes a great degree of intraexonic splicing. This high degree of splicing together with the lack of a GT donor site in the last exon, and the close proximity of YL-1 and TMOD4, may account for the intergenic splicing between these genes.
###end p 22
###begin p 23
Hatched rectangles represent YL-1 exons. Thick black lines represent the intraexonic splice events. The number of amino acids produced by each ORF is in parentheses. Asteriks represent the positions of intraexonic non-canonical splice sites used in multiple ESTs.
###end p 23
###begin p 24
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 80 86 80 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4.</italic>
###xml 143 147 143 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 217 218 217 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 283 287 283 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 89 94 <span type="species:ncbi:9606">human</span>
###xml 295 298 <span type="species:ncbi:10116">rat</span>
We also wanted to determine whether the YL-1 expression pattern overlapped with TMOD4. A human multiple tissue Northern blot was probed with a YL-1 RT-PCR product revealing a single 1.4-1.6 kb band in all lanes (Fig. 4). This is consistent with the reported ubiquitous expression of YL-1 in the rat [25].
###end p 24
###begin p 25
###xml 48 52 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human multiple tissue Northern blot probed with YL-1 RT-PCR product revealed a single highly expressed transcript between 1.4-1.6 kb in all tissues.
###end p 25
###begin title 26
Discussion
###end title 26
###begin p 27
###xml 137 150 137 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">contain TMOD2</italic>
###xml 155 160 155 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 220 232 220 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tropomodulin</italic>
###xml 293 298 293 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD2</italic>
###xml 311 316 311 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 426 431 426 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD2</italic>
###xml 436 441 436 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 327 335 <span type="species:ncbi:9606">patients</span>
Sequencing PCR fragments and genomic subclones from phage artificial chromosomes (PACs) and bacterial artificial chromosomes (BACs) that contain TMOD2 and TMOD4 allowed us to determine the genomic structure of these two Tropomodulin genes. Although mutational analysis of the coding region of TMOD2 in ALS5 and TMOD4 in LGMD1B patients failed to reveal any point mutations, small deletions, or polymorphisms, we did find that TMOD2 and TMOD4 consist of nine coding exons and at least one 5' untranslated exon (E0).
###end p 27
###begin p 28
###xml 56 61 56 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD1</italic>
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tmod1</italic>
###xml 113 115 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 245 250 245 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 385 390 385 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD2</italic>
###xml 395 400 395 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 462 467 462 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD2</italic>
###xml 565 566 565 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 695 701 695 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4,</italic>
This is identical to the genomic structure reported for TMOD1 and Tmod1 by Chu and colleagues and Conley et al. [27,41]. In addition, they identified an 86 bp 5' UTR exon which was expressed in a tissue-specific manner. We performed 5' RACE for TMOD4 and identified only a single 93 bp 5' UTR exon (E0) which lies 1006 bp from coding exon 1. We did not examine whether the E0 exons of TMOD2 and TMOD4 were expressed in a tissue-specific manner. In addition, the TMOD2 transcript is approximately 9.5-10 kb in length and our reported cDNA only accounts for 2.47 kb [8]. Therefore, there are additional UTR exons or sequence that we have not identified in this study. This may not be the case for TMOD4, because our reported cDNA in addition to the 93 base pairs from the E0 sequence and the additional 9 bp from the 3' end produces a transcript of the same size as the major transcript seen by Northern. However, the larger transcripts (2.4 and 3.0 kb) seen on Northern may contain additional sequence that we were unable to identify in this study, or may represent incompletely spliced transcripts.
###end p 28
###begin p 29
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
EST database searches in conjunction with the YL-1 genomic structure allowed us to identify three unique intraexonic splicing events. Two of the three events theoretically would produce truncated proteins with little similarity to the normal protein. These splicing events do not use the canonical AG and GT splice sites, nor do they use the rarer GC, AT, or AC splice sites. This may represent yet another form of splicing for the creation of unique transcripts and, or gene regulation.
###end p 29
###begin p 30
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 63 69 63 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4,</italic>
###xml 264 270 264 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et. al</italic>
###xml 296 327 296 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myelodysplasia syndrome 1(MDS1)</italic>
###xml 369 403 369 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ecotropic viral integration site 1</italic>
###xml 521 523 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 539 586 539 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Galactose-1-phosphate uridylytransferase (GALT)</italic>
###xml 680 729 680 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Interleukin-11 receptor &#945;-chain (IL-11R&#945;)</italic>
###xml 730 732 722 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1049 1080 1041 1072 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HERV-HLTR associating 1 (HHLA1)</italic>
###xml 1091 1109 1083 1101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">otoconin-90 (OC90)</italic>
###xml 1231 1233 1223 1225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1285 1297 1277 1289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">doppel (Dpl)</italic>
###xml 1386 1388 1378 1380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 1661 1667 1653 1659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">doppel</italic>
###xml 1895 1897 1887 1889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1898 1900 1890 1892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 2088 2090 2080 2082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 2091 2093 2083 2085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 2240 2242 2232 2234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 2259 2299 2251 2291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Translin-associated factor X gene (TRAX)</italic>
###xml 2347 2388 2339 2380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Disrupted in schizophrenia gene 1 (DISCI)</italic>
###xml 2389 2391 2381 2383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 533 538 <span type="species:ncbi:9606">human</span>
###xml 925 952 <span type="species:ncbi:11827">human endogenous retrovirus</span>
###xml 954 958 <span type="species:ncbi:11827">HERV</span>
###xml 1049 1053 <span type="species:ncbi:11827">HERV</span>
###xml 1085 1090 <span type="species:ncbi:9606">human</span>
###xml 1202 1207 <span type="species:ncbi:9606">human</span>
###xml 1243 1248 <span type="species:ncbi:10090">mouse</span>
###xml 1380 1384 <span type="species:ncbi:10090">mice</span>
###xml 1431 1435 <span type="species:ncbi:10090">mice</span>
###xml 1678 1683 <span type="species:ncbi:9606">human</span>
We also identified two intergenic transcripts between YL-1 and TMOD4, both of which theoretically would code for truncated versions of YL-1. Intergenic splicing appears to be a rare event: apparently there have been only six other cases reported in mammals. Fears et. al (1996) reported that the Myelodysplasia syndrome 1(MDS1) gene spliced into exon 2 of the adjacent Ecotropic viral integration site 1 (EVI1) gene, producing a unique transcript containing an ORF that produces a GATA-binding transcriptional activator [30,31]. The human Galactose-1-phosphate uridylytransferase (GALT) gene produces an intergenic transcript by skipping its last exon and splicing into exon 2 of Interleukin-11 receptor alpha-chain (IL-11Ralpha)[32]. This produces an intergenic transcript that keeps the endogenous frame of both genes, thereby coding for a theoretical protein with domains from both proteins. A long terminal repeat from a human endogenous retrovirus (HERV) was shown to drive the expression of an intergenic transcript from an unknown gene named HERV-HLTR associating 1 (HHLA1) and human otoconin-90 (OC90) to produce a transcript that is highly expressed in teratocarcinoma cells but not in normal human tissues or cell lines [33]. In the mouse, a Prion-like downstream gene named doppel (Dpl) was found to have an intergenic transcript that is upregulated in Prion-deficient mice [34]. The deletion of the Prion gene in these mice removes the splice acceptor site of exon 3, causing the normal Prion transcript to skip the deleted exon and inadvertently upregulate the normally low-abundance intergenic transcript by forcing it to splice more often to the doppel gene. The human cytochrome P450 2C gene cluster maps to chromosome 10q24 and consists of four genes which are composed of nine exons with conserved exon/intron boundaries, and have been shown to produce intergenic transcripts [35-38]. These transcripts have been identified by RT-PCR for both neighboring genes such as CYP2C18 and CYP2C19, as well as CYP2C members separated by another gene, such as CYP2C18 and CYP2C8 [37,38]. The latter was shown by RT-PCR to include exons from both genes consisting of nine exons and therefore could code for a chimeric CYP2C protein [38]. Recently, the Translin-associated factor X gene (TRAX) was demonstrated to intergenically splice into Disrupted in schizophrenia gene 1 (DISCI)[39]. Several intergenic transcripts were described, the majority of which contain intervening non-coding exons that contain multiple stop codons.
###end p 30
###begin p 31
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 276 280 276 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 357 362 357 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 616 620 616 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 713 718 713 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 813 815 813 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 818 822 818 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 827 832 827 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 946 951 946 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 1102 1106 1102 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 1157 1162 1157 1162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 1237 1242 1237 1242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1,</italic>
###xml 1272 1277 1272 1277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1.</italic>
At least half of the reported cases of intergenic splicing result from skipping the last exon of the upstream gene and the first exon of the downstream gene [32,33,39]. This is thought to be due to the lack of donor and acceptor splice sites in these exons, respectively. For YL-1 exon 6 there is no GT donor site at the end of the exon, and the E0 exon of TMOD4 contains no AG acceptor. Thus the same pattern seen in the other reported intergenic splicing events is born out in our studies. This idea is supported by the fact that we never identified any part of the E0 exon in our RACE products screened using the YL-1 cDNA. However, we did discover this product when we rescreened our RACE products using a 5' TMOD4 probe. Of the previously reported cases, the closest distance between adjacent genes is 4 kb [32]. YL-1 and TMOD4 are separated by 291 bp. Since this genomic region is so small, it raises the question as to the location of the TMOD4 promoter. One possibility is that it lies within the 1006 bp between the E0 exon and coding exon 1, or even within the 291 bp between the E0 exon and YL-1 exon 6. A more intriguing possibility is that the TMOD4 promoter lies further upstream, possibly within the intronic structure of YL-1, or as a shared promoter with YL-1.
###end p 31
###begin p 32
###xml 132 137 132 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 142 146 142 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 370 377 370 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 403 405 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 804 814 804 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1/TMOD4</italic>
Whether these intergenic splice products are biologically relevant is unclear. Due to the fact that the size of the transcripts for TMOD4 and YL-1 overlap (1.3 - 1.5 kb), we cannot demonstrate the co-existence of these intergenic variants by Northern blot analysis. The only reported case in which an intergenic transcript has been shown to produce a functional protein in vivo is the case of MDS1/EVI1[31]. In all other cases, the intergenic transcript or the theoretical protein produced from such transcripts has been difficult to demonstrate by Northern blot analysis, and none have been shown by Western analysis in normal tissues. However, all of these transcripts have been identified by RT-PCR and some by RNase protection assays. Thus, further analysis will be needed to determine if any of the YL-1/TMOD4 intergenic transcripts play an important biological role either at the RNA or protein levels.
###end p 32
###begin title 33
Conclusion
###end title 33
###begin p 34
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD2</italic>
###xml 70 72 70 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">4,</italic>
###xml 78 90 78 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD1/Tmod1,</italic>
###xml 232 237 232 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD2</italic>
###xml 447 451 447 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 508 514 508 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4.</italic>
###xml 614 618 614 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 623 628 623 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 757 761 757 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 766 771 766 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 905 909 905 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 913 918 913 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 1191 1196 1191 1196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prion</italic>
###xml 1201 1207 1201 1207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Doppel</italic>
###xml 1332 1334 1332 1334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 279 287 <span type="species:ncbi:9606">patients</span>
###xml 792 797 <span type="species:ncbi:10090">mouse</span>
###xml 1025 1029 <span type="species:ncbi:10090">mice</span>
Through our genomic analysis we were able to determine that TMOD2 and 4, like TMOD1/Tmod1, share conserved genomic structures consisting of nine coding exons and a single 5' UTR exon (E0). Using primers flanking the coding exons of TMOD2 we performed mutational analysis on ALS5 patients. No mutations or polymorphisms were detected, but our primer pairs and reaction conditions may prove useful for future mutational analyses. We determined that YL-1 comprises six exons, and its last exon lies 291 bp from TMOD4. We also identified six ESTs that show nonconventional splicing. Intergenic splice products between YL-1 and TMOD4 were identified in the EST database, by 5' RACE, and by RT-PCR. Although we did not determine whether this relationship between YL-1 and TMOD4 is conserved in the mouse, it may be an important possibility to consider when devising strategies for targeted deletion not only of YL-1 or TMOD4 but any gene pair in which intergenic splicing occurs. This is clearly illustrated by the Prion deficient mice produced by Sakaguchi et. al (1996) and Moore (1997). In these animals exon 3 and its splice acceptor were deleted, causing a rare intergenic transcript between Prion and Doppel to be highly upregulated and abnormally expressed in the brain, leading to late-onset ataxia and Purkinje cell degeneration[34].
###end p 34
###begin p 35
###xml 53 59 53 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et. al</italic>
###xml 211 213 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 379 383 379 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 388 393 388 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 680 686 680 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1's</italic>
###xml 29 34 <span type="species:ncbi:9606">human</span>
###xml 106 111 <span type="species:ncbi:9606">human</span>
###xml 1016 1021 <span type="species:ncbi:9606">human</span>
The recent completion of the human genome by Ventner et. al (2001) has led to the new prediction that the human genome contains only ~30,000 genes, significantly lower than previous estimates of ~100,000 genes [40]. This estimate does not, however, include the possibility of additional proteins encoded by alternative or intergenic transcripts. The genomic organization between YL-1 and TMOD4 clearly raises the possibility of additional proteins being produced from intergenic transcripts. In addition, it highlights the difficulties that may arise when trying to understand gene regulation for genes that lie extremely close to one another or that form intergenic transcripts. YL-1's intraexonic splicing illustrates yet another level of genomic complexity in that alternative transcripts could be produced from the use of non-canonical splice sites that lie even within an individual exon. This, in conjunction with intergenic splicing, may significantly increase the number of predicted proteins encoded by the human genome and will certainly pose a challenge for anyone trying to decipher genomic organization and regulation.
###end p 35
###begin title 36
Materials and Methods
###end title 36
###begin title 37
Genomic organization and sequence analysis of TMOD2, TMOD4, and YL-1
###end title 37
###begin p 38
###xml 136 141 136 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD2</italic>
###xml 163 168 163 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 173 177 173 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 370 375 <span type="species:ncbi:9606">human</span>
###xml 446 451 <span type="species:ncbi:9606">human</span>
The genomic organization of each gene was determined using two methods. The first involved PCR amplification from either PAC 61J10 (for TMOD2) or BAC HB342I3 (for TMOD4 and YL-1) using primers within each exon to amplify the exon and the intervening intron and use it as a substrate for sequencing the exon-intron boundaries. We also digested PAC 61J10 (from the RPCI-1 human PAC library, Roswell Park Cancer Institute) and BAC HB342I3 (from the human CITB BAC library. Research Genetics, Inc.) with RSAI and then subcloned the DNA fragments into pZero 2.0 according to the manufacturer's instructions. We screened colonies by hybridization using the cDNA for each gene as a probe. All labeling reactions for all procedures were performed using the Megaprime DNA labeling system (Amersham Pharmacia Biotech, Piscataway, NJ). Positive colonies were isolated and sequenced using a PRISM BigDye Terminator Cycle sequencing kit and an ABI 3700 automated DNA sequencer (Perkin-Elmer Applied Biosystems, Foster City, CA).
###end p 38
###begin title 39
Mutational Analysis of TMOD2 for ALS5 and TMOD4 for LGMD1B
###end title 39
###begin p 40
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD2</italic>
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 127 128 127 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 237 238 236 237 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 519 520 504 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 56 63 <span type="species:ncbi:9606">patient</span>
The coding exons of TMOD2 and TMOD4 were amplified from patient lymphoblast genomic DNA using primers flanking the exon (Table 2). Reaction conditions were as follows for a 50 mul PCR reaction : Perkin-Elmer Cetus PCR buffer; 1.5 mM MgCl2, 0.25 mM dNTPs, 1.5 mul of each primer (10 muM), 1% DMSO, 5 U of Taq polymerase (Life Technologies). Thermocycler conditions were as follows for a Perkin Elmer 9600 thermocycler: 94degreesC for 4 min, followed by 35 cycles of 94degreesC for 30 s, annealing temperature (see Table 2) for 30 s, 72degreesC for 1 min, and a final extension of 72degreesC for 10 min. The resulting PCR products were subjected to agarose gel electrophoresis and the DNA was recovered from excised bands using the Qiagen Quick Gel Extraction Kit (CAT# 28706). Each PCR product was then sequenced.
###end p 40
###begin title 41
5' and 3' Rapid Amplification of cDNA ends for TMOD4
###end title 41
###begin p 42
###xml 99 104 99 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 168 174 168 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4,</italic>
###xml 1362 1363 1318 1319 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1462 1466 1418 1422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 1809 1814 1765 1770 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TMOD4</italic>
###xml 19 24 <span type="species:ncbi:9606">Human</span>
###xml 52 55 <span type="species:ncbi:9685">Cat</span>
We used Clontech's Human Heart Marathon-Ready cDNA (Cat # 7404-1) to perform 5' and 3' RACE to the TMOD4 gene. Nested primers were designed within exon 9 and exon 2 of TMOD4, TMOD4EX9RACE5'.1 5'TACAGGAAAGGAGGACAGATGAGG3', and TMOD4EX9RACE5'.2 5'GATTTAAGTGTCCAGTGCTCCCAG3', and TMOD4EX2RACE5'.1 5'GGGCACCAAGTCATCACGCTCT3', TMOD4EX2RACE5' .2 5'CCAAGTACTGCAAAAGGGCCTC3', TMOD4EX2RACE3'.1 5'GGACTAAGACAACGTGACCAGACA3', and TMOD4EX2RACE3' .2 5'GAGGCCCTTTTGCAGTACTTGG3'. The initial RACE reaction to identify intergenic RACE products was performed using the gene specific primer, TMOD4RACE5'.1, and Clontech's AP1 primer in a 50 mul reaction using the Roche High Fidelity Kit (CAT# 1-732-641). Thermocycler conditions for a PE9600 were as follows: 94degreesC for 5 min, followed by 10 cycles of 94degreesC for 30 s, 71degreesC for 30 s, 72degreesC for 4 min; followed by one cycle of 94degreesC for 30 s, 68degreesC for 4 min 20 s, followed by 17 additional cycles each adding 20 s to each extension; final extension at 72degreesC for 10 min. 5 mul of a 1:50 dilution of the product from the first RACE reaction served as template for the second nested RACE reaction. Reaction and thermocycler conditions were the same as before except gene specific primer 2, TMOD4RACE5'.2, and Clontech's AP2 primer were used. RACE products were then subcloned into pbluescript KS II+ using TA vector cloning. Positive products were then identified by colony hybridization using the YL-1 cDNA as a probe. A secondary screening was then performed using exon 2 primers TMOD4EX2RACE5'.1, followed by a second round of race using TMOD4EX2RACE5'.2. Likewise the 3' RACE was performed using TMOD4EX2RACE3'.1, followed by TMOD4EX2RACE3'.2. RACE products were then subcloned and identified by using either a 5' or 3' probes made from the TMOD4 cDNA. Positive RACE products were sequenced.
###end p 42
###begin title 43
RT-PCR of YL-1 and Expression Analysis of YL-1
###end title 43
###begin p 44
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1,</italic>
###xml 386 387 380 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 505 509 499 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YL-1</italic>
###xml 123 128 <span type="species:ncbi:9606">human</span>
###xml 561 566 <span type="species:ncbi:9606">Human</span>
For RT-PCR of YL-1, we performed the same procedure as described in Cox and Zoghbi (2000). Exceptions were the RNA source, human heart poly (A)+ RNA, (Clontech, 6533-1), primers were YL1-35, GTAGGCGGTATGAGTTTG, and YL1-1277, AAAACACAACGAAACCTG, respectively, and the annealing temperature was 53degreesC. The resulting RT-PCR product was subcloned using TA cloning into pbluescript KSII+. This product was then sequenced to confirm that it matched the reported cDNA. We examined the expression pattern of YL-1 using this RT-PCR product as a probe on a Clontech Human multiple tissue Northern blot (CAT# #7760-1).
###end p 44
###begin title 45
Acknowledgements
###end title 45
###begin p 46
This work was supported by the Howard Hughes Medical Institute (HYZ) and the Medical Scientist Training Program (PRC).
###end p 46
###begin article-title 47
Tropomodulin caps the pointed ends of actin filaments.
###end article-title 47
###begin article-title 48
###xml 42 47 <span type="species:ncbi:9606">human</span>
Molecular cloning and characterization of human fetal liver tropomodulin. A tropomyosin-binding protein.
###end article-title 48
###begin article-title 49
###xml 16 19 <span type="species:ncbi:10116">rat</span>
Tropomodulin in rat cardiac muscle. Localization of protein is independent of messenger RNA distribution during myofibrillar development.
###end article-title 49
###begin article-title 50
###xml 73 78 <span type="species:ncbi:10090">mouse</span>
Cloning of tropomodulin cDNA and localization of gene transcripts during mouse embryogenesis.
###end article-title 50
###begin article-title 51
N-tropomodulin: a novel isoform of tropomodulin identified as the major binding protein to brain tropomyosin.
###end article-title 51
###begin article-title 52
###xml 0 7 <span type="species:ncbi:9031">Chicken</span>
Chicken skeletal muscle tropomodulin: novel localization and characterization.
###end article-title 52
###begin article-title 53
Identification of a novel tropomodulin isoform, skeletal tropomodulin, that caps actin filament pointed ends in fast skeletal muscle.
###end article-title 53
###begin article-title 54
###xml 61 66 <span type="species:ncbi:9606">human</span>
###xml 96 101 <span type="species:ncbi:10090">mouse</span>
Sequencing, expression analysis, and mapping of three unique human tropomodulin genes and their mouse orthologs.
###end article-title 54
###begin article-title 55
Gelsolin, a multifunctional actin regulatory protein.
###end article-title 55
###begin article-title 56
Effects of CapZ, an actin capping protein of muscle, on the polymerization of actin.
###end article-title 56
###begin article-title 57
A new function for adducin. Calcium/calmodulin-regulated capping of the barbed ends of actin filaments.
###end article-title 57
###begin article-title 58
Defining actin filament length in striated muscle: rulers and caps or dynamic stability?
###end article-title 58
###begin article-title 59
###xml 98 103 <span type="species:ncbi:9031">chick</span>
Requirement of pointed-end capping by tropomodulin to maintain actin filament length in embryonic chick cardiac myocytes.
###end article-title 59
###begin article-title 60
Altered expression of tropomodulin in cardiomyocytes disrupts the sarcomeric structure of myofibrils.
###end article-title 60
###begin article-title 61
###xml 105 109 <span type="species:ncbi:10090">mice</span>
Myofibril degeneration caused by tropomodulin overexpression leads to dilated cardiomyopathy in juvenile mice.
###end article-title 61
###begin article-title 62
Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere.
###end article-title 62
###begin article-title 63
A molecular basis for familial hypertrophic cardiomyopathy: an alpha/beta cardiac myosin heavy chain hybrid gene.
###end article-title 63
###begin article-title 64
A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation.
###end article-title 64
###begin article-title 65
###xml 110 115 <span type="species:ncbi:9606">human</span>
Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle.
###end article-title 65
###begin article-title 66
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse model of a familial hypertrophic cardiomyopathy mutation in alpha-tropomyosin manifests cardiac dysfunction.
###end article-title 66
###begin article-title 67
Hypertrophic cardiomyopathy: an update.
###end article-title 67
###begin article-title 68
Linkage of a commoner form of recessive amyotrophic lateral sclerosis to chromosome 15ql5-q22 markers.
###end article-title 68
###begin article-title 69
Genetic localization of a newly recognized autosomal dominant limb-girdle muscular dystrophy with cardiac involvement (LGMD1B) to chromosome 1q11-21.
###end article-title 69
###begin article-title 70
Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B).
###end article-title 70
###begin article-title 71
###xml 29 34 <span type="species:ncbi:9606">human</span>
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
Molecular cloning of a novel human cDNA on chromosome 1q21 and its mouse homolog encoding a nuclear protein with DNA-binding ability.
###end article-title 71
###begin article-title 72
Forced expression of YL-1 protein suppresses the anchorage-independent growth of Kirsten sarcoma virus-transformed NIH3T3 cells.
###end article-title 72
###begin article-title 73
###xml 24 29 <span type="species:ncbi:10090">mouse</span>
###xml 34 39 <span type="species:ncbi:9606">human</span>
Genomic organization of mouse and human erythrocyte tropomodulin genes encoding the pointed end capping protein for the actin filaments.
###end article-title 73
###begin article-title 74
Genomic sequence, splicing, and gene annotation.
###end article-title 74
###begin article-title 75
Analysis of canonical and non-canonical splice sites in mammalian genomes.
###end article-title 75
###begin article-title 76
Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family.
###end article-title 76
###begin article-title 77
The leukemia-associated gene MDS1/EVI1 is a new type of GATA-binding transactivator.
###end article-title 77
###begin article-title 78
###xml 43 48 <span type="species:ncbi:9606">human</span>
Cotranscription and intergenic splicing of human galactose-1-phosphate uridylyltransferase and interleukin-11 receptor alpha-chain genes generate a fusion mRNA in normal cells. Implication for the production of multidomain proteins during evolution.
###end article-title 78
###begin article-title 79
###xml 30 34 <span type="species:ncbi:11827">HERV</span>
###xml 76 81 <span type="species:ncbi:9606">human</span>
Intergenic splicing between a HERV-H endogenous retrovirus and two adjacent human genes.
###end article-title 79
###begin article-title 80
###xml 40 44 <span type="species:ncbi:10090">mice</span>
Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel.
###end article-title 80
###begin article-title 81
A 2.4-megabase physical map spanning the CYP2C gene cluster on chromosome 10q24.
###end article-title 81
###begin article-title 82
###xml 73 78 <span type="species:ncbi:9606">human</span>
Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily [published erratum appears in Biochemistry 1993 Feb 9;32(5):1390].
###end article-title 82
###begin article-title 83
###xml 118 123 <span type="species:ncbi:9606">human</span>
RNA molecules containing exons originating from different members of the cytochrome P450 2C gene subfamily (CYP2C) in human epidermis and liver.
###end article-title 83
###begin article-title 84
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human CYP2C locus: a prototype for intergenic and exon repetition splicing events.
###end article-title 84
###begin article-title 85
###xml 50 55 <span type="species:ncbi:9606">human</span>
Chromosomal location and genomic structure of the human translin-associated factor X gene (TRAX; TSNAX) revealed by intergenic splicing to DISCI, a gene disrupted by a translocation segregating with schizophrenia [In Process Citation].
###end article-title 85
###begin article-title 86
###xml 20 25 <span type="species:ncbi:9606">Human</span>
The Sequence of the Human Genome.
###end article-title 86
###begin article-title 87
Leiomodins: larger members of the tropomodulin (Tmod) gene family.
###end article-title 87
###begin article-title 88
Actin dynamics at pointed ends regulates thin filament length in striated muscle.
###end article-title 88

